PFWA
REGN icon

Paces Ferry Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Paces Ferry Wealth Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$310K Sell
497
-13
-3% -$8.85K 0.11% 96
2026
Q1 		$394K Hold
510
– – 0.16% 80
2025
Q4 		$394K Sell
510
-11
-2% -$7.47K 0.16% 82
2025
Q3 		$293K Sell
521
-27
-5% -$15.3K 0.12% 99
2025
Q2 		$288K Buy
548
+28
+5% +$15.6K 0.13% 93
2025
Q1 		$330K Buy
520
+67
+15% +$46.1K 0.16% 86
2024
Q4 		$323K Sell
453
-39
-8% -$32.7K 0.16% 85
2024
Q3 		$517K Sell
492
-3
-0.6% -$3.34K 0.3% 55
2024
Q2 		$520K Sell
495
-19
-4% -$18.4K 0.31% 54
2024
Q1 		$495K Sell
514
-14
-3% -$13.3K 0.32% 59
2023
Q4 		$464K Sell
528
-8
-1% -$6.59K 0.32% 59
2023
Q3 		$441K Sell
536
-7
-1% -$5.5K 0.35% 59
2023
Q2 		$390K Sell
543
-1
-0.2% -$771 0.29% 64
2023
Q1 		$447K Buy
544
+22
+4% +$16.6K 0.36% 56
2022
Q4 		$377K Sell
522
-116
-18% -$85.6K 0.37% 65
2022
Q3 		$439K Buy
638
+8
+1% +$5.04K 0.48% 49
2022
Q2 		$372K Sell
630
-176
-22% -$114K 0.37% 59
2022
Q1 		$563K Sell
806
-4
-0.5% -$2.53K 0.45% 48
2021
Q4 		$512K Sell
810
-37
-4% -$22.7K 0.37% 56
2021
Q3 		$513K Sell
847
-8
-0.9% -$4.97K 0.41% 61
2021
Q2 		$478K Sell
855
-14
-2% -$7.09K 0.37% 65
2021
Q1 		$411K Sell
869
-2
-0.2% -$974 0.36% 66
2020
Q4 		$421K Sell
871
-62
-7% -$33.5K 0.38% 65
2020
Q3 		$522K Buy
+933
New +$566K 0.45% 48

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Paces Ferry Wealth Advisors's REGN Position: Q2 2026 in Review

Paces Ferry Wealth Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 2.5% in Q2 2026, selling an estimated $8.85K and leaving 497 shares worth $310K. The position accounts for 0.11% of the portfolio, ranked #96.

Paces Ferry Wealth Advisors first reported a position in REGN in Q3 2020 and has held it in 24 quarters since. The position peaked at $563K in Q1 2022. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Paces Ferry Wealth Advisors held 497 shares of Regeneron Pharmaceuticals worth $310K as of Q2 2026.
  • Paces Ferry Wealth Advisors sold 13 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $8.85K.
  • Regeneron Pharmaceuticals made up 0.11% of Paces Ferry Wealth Advisors's portfolio in Q2 2026, its #96 holding.
  • Paces Ferry Wealth Advisors first reported a position in Regeneron Pharmaceuticals in Q3 2020 and has held it in 24 quarters since.
  • Paces Ferry Wealth Advisors's Regeneron Pharmaceuticals position peaked at $563K in Q1 2022.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Paces Ferry Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.